Status:
COMPLETED
Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids
Lead Sponsor:
Phonak AG, Switzerland
Conditions:
Hearing Loss, Bilateral or Unilateral
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and f...
Detailed Description
This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The focus is to compare a new hearing aid product generation with the one on the...
Eligibility Criteria
Inclusion
- all kinds of hearing loss (sensorineural, conductive, combined)
- all kinds of hearing loss (flat, sloping) which are in the fitting range of the hearing aids
- mother tongue (swiss) german
Exclusion
- Subjects
- with a reduced mobility unable to attend weekly study appointments
- without access to a number of different hearing situations
- with strongly reduced ability to describe auditory impressions and the usage of the hearing aids
- which are uncooperative so that it is not possible to record a valid pure tone audiogram
- with a strongly reduced dexterity
- with psychological problems
- central hearing disorders
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT02298452
Start Date
May 1 2013
End Date
September 1 2015
Last Update
May 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phonak AG
Stäfa, Canton of Zurich, Switzerland, 8712